Literature DB >> 11337187

Prevalence and phenotypes of erythromycin-resistant Streptococcus pneumoniae in Shanghai, China.

M Wang1, Y Zhang, D Zhu, F Wang.   

Abstract

Bacterial resistance of Streptococcus pneumoniae against erythromycin and clindamycin and resistance phenotypes of erythromycin-resistant Streptococcus pneumoniae were investigated. The MICs of erythromycin and clindamycin against 345 strains of Streptococcus pneumoniae were tested with agar dilution method; the phenotypes of erythromycin-resistant Streptococcus pneumoniae were detected by double-disk test. One hundred and eighty-three and 171 of 345 (53.0% and 49.6%) of isolates had MICs > or =1 microg/ml for erythromycin and for clindamycin. Among erythromycin-resistant Streptococcus pneumoniae, the percentage of cMLS, iMLS and M phenotype was 90.3% (159/176), 5.7% (10/176) and 4.0% (7/176), respectively. The incidence of erythromycin-resistant Streptococcus pneumoniae is very high in Shanghai. The main phenotype is cMLS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337187     DOI: 10.1016/s0732-8893(01)00217-6

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  4 in total

Review 1.  Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review.

Authors:  Setareh Mamishi; Sepideh Moradkhani; Shima Mahmoudi; Reihaneh Hosseinpour-Sadeghi; Babak Pourakbari
Journal:  Iran J Microbiol       Date:  2014-08

2.  Mycobacterium kansasii Subtype I Is Associated With Clarithromycin Resistance in China.

Authors:  Yanming Li; Yu Pang; Xunliang Tong; Huiwen Zheng; Yanlin Zhao; Chen Wang
Journal:  Front Microbiol       Date:  2016-12-26       Impact factor: 5.640

Review 3.  Antibiotic resistance amongst healthcare-associated pathogens in China.

Authors:  Saber Yezli; Han Li
Journal:  Int J Antimicrob Agents       Date:  2012-09-20       Impact factor: 5.283

4.  Molecular characteristics of erythromycin-resistant Streptococcus pneumoniae from pediatric patients younger than five years in Beijing, 2010.

Authors:  Lin Zhou; Xiang Ma; Wei Gao; Kai-Hu Yao; A-Dong Shen; Sang-Jie Yu; Yong-Hong Yang
Journal:  BMC Microbiol       Date:  2012-10-09       Impact factor: 3.605

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.